ResearcherSeoul National UniversityActive in the last 2 years
Jae Hyeong Kim
Matched on ORCID iD 0000-0003-4675-5305; OpenAlex author ID A5100690136. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 7
- Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations. Co-author DOI 10.1016/j.canlet.2025.218176↗
- Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance. Co-author DOI 10.4251/wjgo.v17.i9.109055↗
- Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer. Co-author DOI 10.3233/cbm-210490↗
- Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 tria… Co-author DOI 10.1016/j.gie.2020.02.012↗
- Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells. Co-author DOI 10.1038/s41598-020-73474-6↗
- Involvement of the NF-κB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in Pancreatic Cancer Cells. Co-author DOI 10.7150/jca.46173↗
- Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells. Co-author DOI 10.1038/s41598-019-54478-3↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuna Youn · 7 shared papers, 2019–2026 · strength 1.29
- Paper Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations. DOI 10.1016/j.canlet.2025.218176↗
- Paper Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic can… DOI 10.4251/wjgo.v17.i9.109055↗
- Paper Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer. DOI 10.3233/cbm-210490↗
- Jin‐Hyeok Hwang · 7 shared papers, 2019–2026 · strength 1.29
- Paper Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations. DOI 10.1016/j.canlet.2025.218176↗
- Paper Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic can… DOI 10.4251/wjgo.v17.i9.109055↗
- Paper Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer. DOI 10.3233/cbm-210490↗
- Jaihwan Kim · 5 shared papers, 2020–2026 · strength 0.90
- Paper Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations. DOI 10.1016/j.canlet.2025.218176↗
- Paper Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer. DOI 10.3233/cbm-210490↗
- Paper Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells. DOI 10.1038/s41598-020-73474-6↗
- Jong-Chan Lee · 4 shared papers, 2020–2026 · strength 0.75
- Paper Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations. DOI 10.1016/j.canlet.2025.218176↗
- Paper Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer. DOI 10.3233/cbm-210490↗
- Paper Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells. DOI 10.1038/s41598-020-73474-6↗
- Kwangrok Jung · 2 shared papers, 2025–2026 · strength 0.57
- Paper Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations. DOI 10.1016/j.canlet.2025.218176↗
- Paper Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic can… DOI 10.4251/wjgo.v17.i9.109055↗
- Ji Kon Ryu · 1 shared paper, 2022 · strength 0.19
- Jong-chan Lee · 1 shared paper, 2020 · strength 0.15
- Dong Woo Shin · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.